PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21720156-4	2011	METHODS: We utilized young transgenic Ren2 rats (R2-T) and Sprague-Dawley rats (SD-T) treated with the Ang type 1 receptor (AT(1)R) blocker telmisartan (2 mg   kg(-1)   day(-1)) or vehicle (R2-C; SD-C) for 3 weeks to examine PT structure and function.	Telmisartan	140-151	angiotensin II receptor, type 1a	Rattus norvegicus	103-130